These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 33422062)
1. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells. Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062 [TBL] [Abstract][Full Text] [Related]
2. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
3. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice. Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637 [TBL] [Abstract][Full Text] [Related]
4. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate. Salehi R; Rasouli S; Hamishehkar H Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723 [TBL] [Abstract][Full Text] [Related]
5. pH and Reduction Dual-Responsive Nanogels as Smart Nanocarriers to Resist Doxorubicin Aggregation. Maruf A; Milewska M; Lalik A; Wandzik I Molecules; 2022 Sep; 27(18):. PubMed ID: 36144713 [TBL] [Abstract][Full Text] [Related]
6. Dual responsive magnetic composite nanogels for thermo-chemotherapy. Indulekha S; Arunkumar P; Bahadur D; Srivastava R Colloids Surf B Biointerfaces; 2017 Jul; 155():304-313. PubMed ID: 28448900 [TBL] [Abstract][Full Text] [Related]
7. Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin. Lin JT; Ye QB; Yang QJ; Wang GH Colloids Surf B Biointerfaces; 2019 Aug; 180():93-101. PubMed ID: 31035057 [TBL] [Abstract][Full Text] [Related]
8. Zwitterionic Polymer Micelles with Dual Conjugation of Doxorubicin and Curcumin: Synergistically Enhanced Efficacy against Multidrug-Resistant Tumor Cells. Zhao G; Sun Y; Dong X Langmuir; 2020 Mar; 36(9):2383-2395. PubMed ID: 32036662 [TBL] [Abstract][Full Text] [Related]
9. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818 [TBL] [Abstract][Full Text] [Related]
10. Preparation of thermo/redox/pH-stimulative poly(N-isopropylacrylamide-co-N,N'-dimethylaminoethyl methacrylate) nanogels and their DOX release behaviors. Gao D; Duan L; Wu M; Wang X; Sun Z; Zhang Y; Li Y; He P J Biomed Mater Res A; 2019 Jun; 107(6):1195-1203. PubMed ID: 30650226 [TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment responsive nanogels as a smart triggered release platform for enhanced intracellular delivery of doxorubicin. Kumar P; Behl G; Kaur S; Yadav N; Liu B; Chhikara A J Biomater Sci Polym Ed; 2021 Feb; 32(3):385-404. PubMed ID: 33054642 [TBL] [Abstract][Full Text] [Related]
12. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983 [TBL] [Abstract][Full Text] [Related]
13. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Baghbani F; Moztarzadeh F Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723 [TBL] [Abstract][Full Text] [Related]
14. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
18. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency. Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025 [TBL] [Abstract][Full Text] [Related]
19. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach. Tefas LR; Sylvester B; Tomuta I; Sesarman A; Licarete E; Banciu M; Porfire A Drug Des Devel Ther; 2017; 11():1605-1621. PubMed ID: 28579758 [TBL] [Abstract][Full Text] [Related]
20. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]